Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16380913 | 0.84 | — | — | |
| SCHEMBL11610762 | 0.70 | CYP3A4 (0.39) | LMNA | |
| SCHEMBL11789705 | 0.69 | NR3C1 (0.35) | LMNA | |
| SCHEMBL11902996 | 0.67 | GLA (0.33) | GLALMNA | |
| SCHEMBL11273637 | 0.67 | TSHR (0.31) | — | |
| SCHEMBL16167274 | 0.65 | GLA (0.33) | GLALMNA | |
| SCHEMBL8530508 | 0.64 | GLA (0.35) | GLALMNA | |
| SCHEMBL30291076 | 0.64 | GLA (0.32) | GLALMNA | |
| SCHEMBL7316737 | 0.62 | — | — | |
| SCHEMBL11707354 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8927750-B2 | Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules | UNIVERSITAET ZU KOELN (DE) | 2015-01-06 | — | — | US | disclosed |
| US-8927750-B2 | Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules | UNIVERSITAET ZU KOELN (DE) | 2015-01-06 | — | — | US | disclosed |
| US-8927750-B2 | Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules | UNIVERSITAET ZU KOELN (DE) | 2015-01-06 | — | — | US | disclosed |
| US-20120202774-A1 | ACYLOXY- AND PHOSPHORYLOXY-BUTADIENE-FE(CO)3 COMPLEXES AS ENZYME-TRIGGERED CO-RELEASING MOLECULES | UNIVERSITAET REGENSBURG (DE) | 2012-08-09 | — | — | US | disclosed |
| US-20120202774-A1 | ACYLOXY- AND PHOSPHORYLOXY-BUTADIENE-FE(CO)3 COMPLEXES AS ENZYME-TRIGGERED CO-RELEASING MOLECULES | UNIVERSITAET REGENSBURG (DE) | 2012-08-09 | — | — | US | disclosed |
| US-20120202774-A1 | ACYLOXY- AND PHOSPHORYLOXY-BUTADIENE-FE(CO)3 COMPLEXES AS ENZYME-TRIGGERED CO-RELEASING MOLECULES | UNIVERSITAET REGENSBURG (DE) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202774-A1 | ACYLOXY- AND PHOSPHORYLOXY-BUTADIENE-FE(CO)3 COMPLEXES AS ENZYME-TRIGGERED CO-RELEASING MOLECULES | PPOX, APEH, ACOX3 | GLA 1714/4885LMNA 4172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.